Science and Technology Science and Technology
Mon, May 12, 2025

Tiziana Life Sciences reports purchase of shares by chairman (TLSA:NASDAQ)


Published on 2025-05-12 08:42:12 -
  Print publication without navigation

  • Tiziana Life Sciences (TLSA) on Monday said that its Executive Chairman and Founder,
  • Gabriele Cerrone, has purchased 15,000 common shares at $1.55 per share, bringing his total holding to 43,252,143 common shares, which is 37.02% of issued share capital.

Tiziana Life Sciences announced that its Chairman, Gabriele Cerrone, purchased 2.5 million ordinary shares of the company on June 23, 2023, at a price of $0.80 per share, totaling an investment of $2 million. This transaction increased Cerrone's total ownership in Tiziana to approximately 8.9% of the company's outstanding shares. The purchase reflects Cerrone's confidence in Tiziana's future prospects, particularly as the company advances its clinical programs, including the development of foralumab, a fully human anti-CD3 monoclonal antibody, for the treatment of multiple sclerosis and other autoimmune and inflammatory diseases.

Read the Full Seeking Alpha Article at:
[ https://seekingalpha.com/news/4446344-tiziana-life-sciences-reports-purchase-of-shares-by-chairman ]